Latest News from: UC Davis Comprehensive Cancer Center

Add to Favorites Subscribe Share
Go to Advanced Search

Showing results

110 of 78
Rosenberg_Aaron.jpg

Article ID: 696030

Stem Cell Transplants Extend Life for Multiple Myeloma Patients

UC Davis Comprehensive Cancer Center

Researchers at UC Davis have confirmed that autologous hematopoietic stem cell transplant improves survival for people suffering from multiple myeloma, yet many potentially eligible patients never undergo the procedure.

Released:
12-Jun-2018 2:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Jonas_29.jpg

Article ID: 690825

Acute Myeloid Leukemia Patients Have Reduced Early Mortality at NCI-Designated Cancer Centers

UC Davis Comprehensive Cancer Center

Researchers at UC Davis have shown that patients with acute myeloid leukemia (AML) who received their care at a National Cancer Institute (NCI) cancer center in California had a dramatically reduced risk of early mortality. Using data from the California Cancer Registry and the Patient Discharge Dataset, the team determined that the risk was reduced by 53 percent. These findings were reported in February in the journal Cancer.

Released:
8-Mar-2018 3:30 PM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 689571

There’s an App for That

UC Davis Comprehensive Cancer Center

UC Davis pathologist Hooman Rashidi is an expert in blood disorders but also a computer programmer. He has married the two disciplines and created must-have learning tools for medical students and residents. His latest is HemeQuiz1, a medical student training app.

Released:
14-Feb-2018 4:00 PM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Murphy-17.jpg

Article ID: 687453

UC Davis Researcher Urges Caution on Engineered Stem Cells

UC Davis Comprehensive Cancer Center

In a commentary published in the Jan. 4 issue of the New England Journal of Medicine, UC Davis researcher William Murphy expressed cautious optimism about efforts to genetically engineer hematopoietic stem cells (HSCs) to temporarily resist cell death during transplantation. While these gene therapy approaches could dramatically improve patient outcomes, Murphy argues that their risks must be carefully studied in diverse models.

Released:
3-Jan-2018 5:05 PM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Heyer_Wolf_190.jpg

Article ID: 685097

Unlocking the Genetics of Cancer

UC Davis Comprehensive Cancer Center

For many, breast cancer is more than just a disease – it’s personal. One in eight women will be diagnosed with breast cancer at some point in their lives.

Released:
28-Nov-2017 3:05 PM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
melnikow.joy.jpg

Article ID: 680184

The Understudied Consequences of Peripheral Neuropathy after Chemotherapy

UC Davis Comprehensive Cancer Center

In two papers published in the Journal of the National Cancer Institute researchers from UC Davis, UCLA and other institutions have found that peripheral neuropathy, which causes pain, numbness, and tingling in hands and/or feet, can bother early-stage breast cancer patients years after completing chemotherapy. In addition, a systematic literature review found only a handful of studies that tracked long-term peripheral neuropathy, leaving little data for patients and clinicians to make informed decisions.

Released:
29-Aug-2017 8:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
MigliorettiDiana_0270.jpg

Article ID: 678113

UC Davis-Led Group Receives $17 Million in NCI Funds

UC Davis Comprehensive Cancer Center

Breast Cancer Surveillance Consortium (BCSC) investigators have received a $17 million program project grant renewal from the National Cancer Institute to study the effectiveness of different breast cancer screening and surveillance strategies using digital mammography, digital breast tomosynthesis (3D mammography), and breast MRI. Co-led by UC Davis researcher Diana Miglioretti, the consortium seeks to ensure that women get personalized care based on their individual risk and preferences.

Released:
19-Jul-2017 6:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 677411

How Treating a Dog's Tumors May Help in the Fight Against Human Cancer

UC Davis Comprehensive Cancer Center

With its internationally renowned school of veterinary medicine and its NCI-designated comprehensive cancer center, UC Davis is uniquely positioned to harness the power of each to tackle one of life’s greatest challenges: cancer.

Released:
6-Jul-2017 2:00 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Keegan072.jpg
  • Embargo expired:
    20-Apr-2017 11:00 AM EDT

Article ID: 673069

Second Cancers Deadlier in Young Patients

UC Davis Comprehensive Cancer Center

Second cancers in children and adolescents and young adults (AYA) are far deadlier than they are in older adults and may partially account for the relatively poor outcomes of cancer patients ages 15-39 overall, a new study by UC Davis researchers has found."Second Primary Malignant Neoplasms and Survival in Adolescent and Adult Cancer Survivors" is published today in JAMA Oncology.

Released:
18-Apr-2017 2:00 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
ferrara.kathy.jpg

Article ID: 671773

Hitting Cancer with High-Intensity Ultrasound and Immunotherapy

UC Davis Comprehensive Cancer Center

In a new study published today in JCI Insight, UC Davis researchers have shown that combining high-intensity focused ultrasound with two immunotherapies (a PD-1 checkpoint inhibitor and TLR9 agonist) can produce excellent response rates in mouse models of epithelial cancer. They also found that, for the combination to be effective, immunotherapies must come first.

Released:
23-Mar-2017 3:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Showing results

110 of 78





Chat now!